2m 2m 2m 2m 2m 2m 2m
Accendra Health (ACH)
NYSE
$0.25+$0.01 (+5.96%)
Price as of Oct 16, 2026 7:46 PM EDT- $18.1MMarket Cap
- N/A1-Year Change
- Medical DistributionIndustry
Accendra Health (ACH)
$0.25+$0.01 (+5.96%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.8B -74.19% | 10.7B +3.55% | 10.3B +3.80% | 10.0B +1.74% | |
Cost of Revenue | 1.5B -82.64% | 8.5B +3.32% | 8.2B +0.98% | 8.1B -1.73% | |
Gross Profit | 1.3B -41.90% | 2.2B +4.42% | 2.1B +16.36% | 1.8B +20.69% | |
Sales and Marketing Expense | 1.1B -44.10% | 1.9B +5.31% | 1.8B +11.01% | 1.6B +46.27% | |
Research and Development Expense | N/A N/A | -13.0M -1.52% | -13.2M N/A | N/A N/A | |
Depreciation and Amortization Expense | 214.5M -18.98% | 264.8M -7.86% | 287.4M +25.67% | 228.7M +152.33% | |
Total Operating Expenses | 3.8B +99.09% | 1.9B +5.31% | 1.8B +11.01% | 1.6B +46.27% | |
Operating Profit | 27.5M +113.22% | -207.8M -298.81% | 104.5M -26.87% | 142.9M -61.21% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -107.2M -25.47% | -143.8M -8.94% | -157.9M +22.52% | -128.9M +168.02% | |
Interest Income and Expense and Net | -107.2M -25.47% | -143.8M -8.94% | -157.9M +22.52% | -128.9M +168.02% | |
Total Nonoperating Income and Expense | -3.9M -15.82% | -4.7M -3.18% | -4.8M +54.49% | -3.1M -2.03% | |
Income before Taxes | -102.0M -71.47% | -357.4M +552.99% | -54.7M -602.49% | 10.9M -96.06% | |
Income Taxes | 729,000 -86.32% | 5.3M +139.69% | -13.4M +16.76% | -11.5M -120.84% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Net Income | -1.1B +203.47% | -362.7M +778.15% | -41.3M -284.47% | 22.4M -89.90% | |
Net Income from Continuing Operations Applicable to Common | -102.0M -71.47% | -357.4M +552.99% | -54.7M -344.43% | 22.4M -89.90% | |
Basic EPS and Net Income | -14.31 +202.54% | -4.73 +775.93% | -0.54 -280.00% | 0.30 -90.16% | |
Diluted EPS and Net Income | -14.31 +202.54% | -4.73 +775.93% | -0.54 -286.21% | 0.29 -90.14% | |
Basic Weighted Average Shares | 76.9M +0.20% | 76.7M +1.26% | 75.8M +1.73% | 74.5M +2.41% | |
Diluted Weighted Average Shares | 76.9M +0.20% | 76.7M +1.26% | 75.8M -0.57% | 76.2M +0.97% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 282.0M +471.04% | 49.4M -79.68% | 243.0M +249.86% | 69.5M +24.69% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 282.0M +471.04% | 49.4M -79.68% | 243.0M +249.86% | 69.5M +24.69% | |
Total Current Assets | 547.9M -72.89% | 2.0B -3.89% | 2.1B -8.38% | 2.3B -1.15% | |
Accumulated Depreciation | 207.6M -63.27% | 565.1M +3.43% | 546.4M +21.34% | 450.3M +34.61% | |
Property and Plant and Equipment and Net | 256.2M -49.71% | 509.3M -6.37% | 544.0M -5.93% | 578.3M +82.28% | |
Total Long-Term Assets | 174.0M +24.16% | 140.2M -6.15% | 149.3M -0.71% | 150.4M +45.24% | |
Total Assets | 2.5B -47.34% | 4.7B -8.58% | 5.1B -5.44% | 5.4B +52.30% | |
Income Taxes Payable | 19.4M -13.45% | 22.5M -46.09% | 41.7M -31.53% | 60.8M +72.28% | |
Total Short-Term Debt | 250.0M +448.86% | 45.5M -77.99% | 206.9M -92.09% | 2.6B +174.77% | |
Total Current Liabilities | 947.1M -49.46% | 1.9B -0.96% | 1.9B +20.77% | 1.6B +16.55% | |
Total Long-Term Debt | 1.8B -0.45% | 1.8B -4.37% | 1.9B -23.86% | 2.5B +162.04% | |
Total Long-Term Liabilities | 95.5M -4.98% | 100.5M -18.04% | 122.6M +6.65% | 114.9M +5.51% | |
Total Liabilities | 2.9B -28.80% | 4.1B -1.88% | 4.2B -6.11% | 4.4B +70.92% | |
Retained Earnings | -1.1B -18,033.10% | 6.0M -98.37% | 368.7M -10.07% | 410.0M +5.78% | |
Total Stockholders Equity | -461.0M -181.56% | 565.2M -38.84% | 924.2M -2.27% | 945.6M +0.76% | |
Total Shares Outstanding | 76.4M -1.05% | 77.2M +0.85% | 76.5M +0.35% | 76.3M +1.12% | |
Cash Flow | |||||
Cash from Operating Activities | -358.1M -321.73% | 161.5M -78.20% | 740.7M +127.91% | 325.0M +161.73% | |
Capital Expenditures | 189.0M -10.37% | 210.9M +10.48% | 190.9M +20.74% | 158.1M +285.73% | |
Cash from Investing Activities | 144.4M +223.93% | -116.5M -15.10% | -137.3M -92.39% | -1.8B +3,264.68% | |
Dividends Paid | N/A N/A | N/A N/A | 0 N/A | 0 -100.00% | |
Cash from Financing Activities | 188.1M +170.28% | -267.6M -35.88% | -417.3M -127.88% | 1.5B +1,256.26% | |
Financials Ratio | |||||
Gross Margin | 46.68% +125.09% | 20.74% +0.84% | 20.56% +12.10% | 18.35% +18.63% | |
Operating Margin | 0.99% +151.21% | -1.94% -291.99% | 1.01% -29.55% | 1.44% -61.88% | |
Return on Assets | -30.97% +316.25% | -7.44% +843.94% | -0.79% -257.07% | 0.50% -92.22% | |
Return on Equity | -2,111.58% +4,235.67% | -48.70% +1,002.42% | -4.42% -285.89% | 2.38% -91.15% | |
Revenue Growth | -74.19% -2,189.47% | 3.55% -6.61% | 3.80% +118.63% | 1.74% -88.70% | |
Current Ratio | 0.58 -46.37% | 1.08 -2.96% | 1.11 -24.14% | 1.47 -15.18% | |
Cash Ratio | 0.30 +1,027.65% | 0.03 -79.46% | 0.13 +190.07% | 0.04 +6.75% | |
Debt-to-Equity Ratio | -4.45 -235.60% | 3.28 +44.49% | 2.27 -57.90% | 5.39 +166.41% | |
Debt-to-Assets Ratio | 0.84 +110.02% | 0.40 -3.33% | 0.41 -56.49% | 0.95 +76.24% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow